| Serial Number | 88108803 |
| Word Mark | CYCLERION |
| Filing Date | Friday, September 7, 2018 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, April 17, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 21, 2020 |
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of ocular and ophthalmological diseases, respiratory system diseases, gastrointestinal system diseases, endocrine system diseases, cardiovascular system diseases, diseases of metabolism, central nervous system diseases, peripheral nervous system diseases, musculoskeletal system diseases, urinary system diseases, kidney diseases, hematological diseases, reproductive system diseases, integumentary system disease, skin and scalp diseases, immune system diseases, mitochondrial diseases, sleep disorders, fibrotic diseases, endothelial dysfunction, thrombosis, ischemia, pain, inflammation, burns, ulcers and wounds, namely, preparations that stimulate guanylate cyclases (sGC), increase the concentration of nitric oxide (NO), increase the concentration of cyclic guanosine monophosphate (cGMP), upregulate the NO-sGC-cGMP (nitric oxide- soluble guanylate cyclases- cyclic guanosine monophosphate) pathway, or utilize a synergistic interaction of the NO-sGC-cGMP (nitric oxide- soluble guanylate cyclases- cyclic guanosine monophosphate) pathway with a complementary signaling pathway; Pharmaceutical preparations, namely, pharmaceutical preparations and substances for the prevention and treatment of ocular and ophthalmological diseases, respiratory system diseases, gastrointestinal system diseases, endocrine system diseases, cardiovascular system diseases, diseases of metabolism, central nervous system diseases, peripheral nervous system diseases, musculoskeletal system diseases, urinary system diseases, kidney diseases, hematological diseases, reproductive system diseases, integumentary system disease, skin and scalp diseases, immune system diseases, mitochondrial diseases, sleep disorders, fibrotic diseases, endothelial dysfunction, thrombosis, ischemia, pain, inflammation, burns, ulcers and wounds |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 17, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Cyclerion Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | Cyclerion Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Monday, April 17, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, April 17, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| Thursday, September 8, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, September 7, 2022 | SOU EXTENSION 5 GRANTED |
| Wednesday, August 31, 2022 | SOU EXTENSION 5 FILED |
| Wednesday, August 31, 2022 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, March 2, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, February 28, 2022 | SOU EXTENSION 4 GRANTED |
| Monday, February 28, 2022 | SOU EXTENSION 4 FILED |
| Monday, February 28, 2022 | SOU TEAS EXTENSION RECEIVED |
| Thursday, September 16, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, September 14, 2021 | SOU EXTENSION 3 GRANTED |
| Tuesday, September 14, 2021 | SOU EXTENSION 3 FILED |
| Tuesday, September 14, 2021 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, March 10, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, March 8, 2021 | SOU EXTENSION 2 GRANTED |
| Monday, March 8, 2021 | SOU EXTENSION 2 FILED |
| Monday, March 8, 2021 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, May 19, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, May 15, 2020 | SOU EXTENSION 1 GRANTED |
| Friday, May 15, 2020 | SOU EXTENSION 1 FILED |
| Friday, May 15, 2020 | SOU TEAS EXTENSION RECEIVED |
| Thursday, May 14, 2020 | CORRECTED NOA E-MAILED |
| Wednesday, May 13, 2020 | DIVISIONAL PROCESSING COMPLETE |
| Sunday, April 26, 2020 | DIVISIONAL REQUEST RECEIVED |
| Tuesday, May 12, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Sunday, April 26, 2020 | TEAS REQUEST TO DIVIDE RECEIVED |
| Tuesday, March 17, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 21, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 21, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 1, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, December 16, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, December 16, 2019 | EXAMINER'S AMENDMENT ENTERED |
| Monday, December 16, 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, December 16, 2019 | EXAMINERS AMENDMENT E-MAILED |
| Monday, December 16, 2019 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, July 9, 2019 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, July 9, 2019 | FINAL REFUSAL E-MAILED |
| Tuesday, July 9, 2019 | FINAL REFUSAL WRITTEN |
| Tuesday, June 25, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, June 25, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 25, 2019 | ASSIGNED TO LIE |
| Wednesday, June 19, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, December 20, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, December 20, 2018 | NON-FINAL ACTION E-MAILED |
| Thursday, December 20, 2018 | NON-FINAL ACTION WRITTEN |
| Tuesday, December 18, 2018 | ASSIGNED TO EXAMINER |
| Monday, September 17, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 11, 2018 | NEW APPLICATION ENTERED |